$8.740
+0.020 (+0.23%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
DMAC Prediction & Forecast by Similar Chart Analysis
Alphio's DMAC stock price prediction model matches the current DiaMedica Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.63 (-1.27%). The 1-week path is $8.75 (+0.12%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy DiaMedica Therapeutics Inc Stock?
DiaMedica Therapeutics Inc (DMAC) is a good buy right now at a current price of $8.72, especially considering its recent 5-day change of +15.19% and an RSI of 67.548, indicating strong momentum. The stock has shown resilience with a 1-year change of +26.74%, suggesting a positive long-term trend. However, investors should be cautious of the widening net loss reported for Q2 2026, which reached -10.1 million USD, indicating ongoing financial challenges. Overall, the positive momentum and potential for recovery in clinical trials outweigh the risks, making DMAC a favorable investment opportunity.
DMAC stock price ended at $8.74 on Monday, after rising +0.23%
DiaMedica Therapeutics Inc (DMAC) last closed at $8.7399998, gaining +0.23%. These facts feed the 1-day and 1-week DMAC price prediction above.
Forecast Drivers
DiaMedica Therapeutics Inc (DMAC) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches DMAC, ranked by similarity.
Seasonality analysis for DMAC
Historically the probability of a positive October return for DMAC is 93.85%. December offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for DMAC
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $4.71 | $4.83 | $4.89 | -44.74% |
| Nov 2026 | $3.93 | $4.46 | $4.86 | -48.97% |
| Dec 2026 | $3.68 | $4.22 | $4.83 | -51.72% |
In 2026, DiaMedica Therapeutics Inc (DMAC) is projected to range from $3.68 to $4.89.
DiaMedica Therapeutics Inc 2026 monthly forecast
In Oct 2026, DiaMedica Therapeutics Inc is projected to average $4.83, with a low of $4.71 and high of $4.89.
In Nov 2026, DiaMedica Therapeutics Inc is projected to average $4.46, with a low of $3.93 and high of $4.86.
In Dec 2026, DiaMedica Therapeutics Inc is projected to average $4.22, with a low of $3.68 and high of $4.83.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.